Ulcerative colitis Trials in Glenview, United States
Conditions / Ulcerative colitis / Glenview, United States
Research into Ulcerative colitis spans multiple therapeutic approaches and trial phases.
11 total trials for this combination
Showing top 10 of 11 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT07186101 | LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis: | RECRUITING | — |
| NCT06581328 | A Study of Vedolizumab in Adults With Ulcerative Colitis or Crohn's Disease in the Community Setting | RECRUITING | — |
| NCT05535946 | ABTECT - Maintenance | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT07184996 | An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis | RECRUITING | — |
| NCT06052059 | A Study to Evaluate Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderately to Severely Active Ulcerative Colitis (MK-7240-001) | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT04857112 | Study Evaluating Efficacy and Safety of Amiselimod (MT-1303) in Mild to Moderate Ulcerative Colitis | COMPLETED | PHASE2 |
| NCT06880744 | A Study to Assess the Change in Disease Activity in Adult Participants With Moderate to Severe Ulcerative Colitis Treated With Risankizumab Compared to Vedolizumab | RECRUITING | PHASE3 |
| NCT03934216 | Safety and Efficacy of Deucravacitinib in Participants With Moderate to Severe Ulcerative Colitis | COMPLETED | PHASE2 |
| NCT04996797 | A Phase 2 Safety and Efficacy Study of Tulisokibart (MK-7240/PRA023) in Subjects With Moderately to Severely Active Ulcerative Colitis (MK-7240-005) | COMPLETED | PHASE2 |
| NCT05507203 | ABTECT-1 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -1 | COMPLETED | PHASE3 |